Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis

NCT04024891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Mydriasis
Dilation

Interventions

DRUG: Phentolamine Mesylate Ophthalmic Solution 1%
OTHER: Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)

Sponsor

Ocuphire Pharma, Inc.